This highlights a level of redundancy between TIMP2 and TIMP3 activities and raises the intriguing idea that combinatorial administration of TIMP2 and TIMP3 to tumors may augment previous anti-tumor findings observed with TIMP2. Here, TIMP2 is linked to neoplasm.